McDonald’s Corp. has finally updated its antibiotics policy that calls for reduced antibiotic usage after a two-year delay.
The fast-food giant’s new policy revealed in Decemebr follows guidelines set out by the World Health Organization (WHO), the World Organization for Animal Health, and other public and animal health groups.
According to McDonald’s, they will focus on the responsible use of medically important antibiotics and be aligned with WHO Guidelines on Antimicrobial Resistance.
The company added that its policy does not permit the routine use of medically important antibiotics for growth promotion or tdisease prevention.
It is committed to usage reduction, where possible without adverse effects on animal health and welfare.
The company has established market-specific targets for the responsible use of antibiotics for 10 in-scope markets, representing over 80 percent of its global beef supply chain.
In 2023, McDonald’s plans to share an update on its antibiotic usage.
However, the Natural Resources Defense Council (NRDC) criticized McDonald’s for failing to detail a rollout plan or a completion date to ensure accountability across the supply chain.
According to Lena Brook, director of food campaigns at NRDC, it is especially disappointing given that McDonald’s, the world’s largest beef buyer, chose optics over substance with its new beef policy update despite the urgency of the global antibiotic resistance crisis.
McDonald’s earned a grade of C from the NDRC for its previous policy. NDRC called McDonald’s updated policy a “new, weaker approach.”


Oil Prices Slip as Middle East Tensions Ease, Heading for Weekly Loss
Gold Prices Climb as Middle East Ceasefire Talks Stir Market Optimism
Lynas Rare Earths Signs Vietnam Deal with LS Eco Energy to Boost Magnet Metal Production
Asian Currencies Stay Muted as Dollar Holds Firm Amid Iran Uncertainty
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
Gold is meant to be a ‘safe haven’ in uncertain times. Why is it crashing amid a war?
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Global Flight Cancellations 2026: Middle East Air Travel Chaos Explained
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
AWS Bahrain Region Disrupted by Drone Activity Amid Middle East Conflict
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
U.S. Praises Kurdistan's Role in Oil Markets Amid Iran War Fallout
9 Tips for Avoiding Tax Season Cyber Scams
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 



